상세정보
Export to Refworks부가기능
Innovations in pharmaceutical manufacturing on the horizon Technical challenges, regulatory issues, and recommendations
상세 프로파일
| 자료유형 | 단행본 |
|---|---|
| 서명/저자사항 | Innovations in pharmaceutical manufacturing on the horizon : Technical challenges, regulatory issues, and recommendations/ Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing, Board on Chemical Sciences and Technology, Division on Earth and Life Studies. |
| 단체저자명 | National Academies of Sciences, Engineering, and Medicine (U.S.), Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing,issuing body. National Academies of Sciences, Engineering, and Medicine (U.S.). Board on Chemical Sciences and Technology.issuing body. National Academies of Sciences, Engineering, and Medicine (U.S.). Division on Earth and Life Studies.issuing body. |
| 발행사항 | Washington, D.C.: National Academies Press, [2021]. |
| 형태사항 | 1 online resource (x, 110 pages): charts. |
| 기타형태 저록 | Print version: Innovations in pharmaceutical manufacturing on the horizon. Washington, D.C. : National Academies Press, 2021 9780309088671 |
| ISBN | 9780309104982 030910498X |
| 서지주기 | Includes bibliographical references. |
| 내용주기 | Front Matter -- Summary -- 1. Introduction -- 2. Innovations in manufacturing drug substances -- 3 Innovations in manufacturing drug products -- 4. New control approaches to enable quality assurance and process capability -- 5. Innovations in integrated, flexible, and distributed manufacturing networks -- 6. Advancing innovation: observations, challenges, opportunities, and recommendations -- Appendix A: Biographic information on the Committee to Identify Innovative Technologies to Advances Pharmaceutical Manufacturing -- Appendix B: Disclosure of unavoidable conflicts of interest -- Appendix C: Workshop and webinar agenda -- Appendix D: Innovations in pharmaceutical manufacturing proceeding of a workshop - in brief -- Appendix E: Barriers to innovations in pharmaceutical manufacturing proceedings of a workshop - in brief. |
| 요약 | In 2002, the U.S. Food and Drug Administration (FDA) launched the Pharmaceutical Quality for the 21st Century Initiative to encourage adoption of innovative technologies that would lead to an agile, flexible pharmaceutical manufacturing sector. The goal was to encourage a transition to manufacturing processes and approaches that could produce high-quality drugs reliably without extensive regulatory oversight. Much progress has been made toward that goal as the industry has developed and advanced new technologies, but more progress is required as recent natural disasters and the coronavirus pandemic have revealed vulnerabilities in supply chains and highlighted the need to modernize pharmaceutical manufacturing further. At the request of the FDA Center for Drug Evaluation and Research (CDER), Innovations in Pharmaceutical Manufacturing on the Horizon identifies emerging technologies - such as product technologies, manufacturing processes, control and testing strategies, and platform technologies - that have the potential to advance pharmaceutical quality and modernize pharmaceutical manufacturing for products regulated by CDER. This report describes many innovations to modernize the manufacture of drug substances and drug products, to advance new control approaches, and to develop integrated, flexible, and distributed manufacturing networks within 5-10 years.--Publisher's website |
| 일반주제명 | Pharmaceutical microbiology --Methodology. |
| 언어 | 영어 |
| 바로가기 |  |
